Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

MMUSTANG BIO, INC.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
M

MUSTANG BIO, INC.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • History
  • News
  • Insider Transactions

News

News

  • Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-101 (IL13Ra2-targeted CAR T-cells) to Treat Astrocytomas and Glioblastoma
    Jul 7, 2025Mustang Bio, Inc. (MBIO) Press Releases
  • Mustang Bio Regains Compliance with Nasdaq Capital Market Requirement
    Mar 5, 2025Mustang Bio, Inc. (MBIO) Press Releases
  • Mustang Bio Announces Sale of Fixed Assets and Exit of Facility
    Feb 27, 2025Mustang Bio, Inc. (MBIO) Press Releases
  • Mustang Bio Regains Compliance with Nasdaq Minimum Bid Price Requirement
    Feb 11, 2025Mustang Bio, Inc. (MBIO) Press Releases
  • Mustang Bio Announces Closing of $8 Million Public Offering
    Feb 10, 2025Mustang Bio, Inc. (MBIO) Press Releases
  • Mustang Bio Announces Pricing of $8 Million Public Offering
    Feb 6, 2025Mustang Bio, Inc. (MBIO) Press Releases
  • Mustang Bio Announces Reverse Stock Split
    Jan 14, 2025Mustang Bio, Inc. (MBIO) Press Releases
  • Mustang Bio Receives Positive Listing Determination from Nasdaq
    Nov 12, 2024Mustang Bio, Inc. (MBIO) Press Releases
  • Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-108 (HSV-1 oncolytic virus) to Treat Malignant Glioma
    Nov 7, 2024Mustang Bio, Inc. (MBIO) Press Releases
  • Mustang Bio Announces Exercise of Warrants for $4 Million Gross Proceeds
    Oct 24, 2024Mustang Bio, Inc. (MBIO) Press Releases
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • History
  • News
  • Insider Transactions